Insider Transactions Reported by 21 Insiders of Cue Biopharma, Inc.

Symbol
CUE on Nasdaq
Location
Boston, MA

Insiders trading volume in the past year

Cue Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael J. Fox Director $3,036,000 05 Jun 2024
Cameron Gray Director $1,896,255 14 Jun 2022
Anish Suri President And Cso $374,361 05 Jun 2024
DANIEL PASSERI CHIEF EXECUTIVE OFFICER, Director $169,515 21 Mar 2025
Pasha Sarraf Director $97,675 +$99,747 30 Dec 2025
Peter A. Kiener Director 02 Jan 2025
Matteo Levisetti Chief Medical Officer 21 Mar 2025
Frank Morich Director 02 Jan 2025
Pamela Garzone Director 02 Jan 2025
Colin Sandercock Svp, General Counsel 26 Sep 2025
Patrick Verheyen Director 02 Jan 2025
Kerri-Ann Millar Chief Financial Officer 21 Mar 2025
FREDERICK W. DRISCOLL Director 02 Jan 2025
TAMAR HOWSON Director 03 Jan 2023
Jill Marie Broadfoot Director 04 Jun 2025
Kenneth Pienta Chief Medical Officer 25 Mar 2022
Usman Azam CHIEF EXECUTIVE OFFICER, Director 29 Sep 2025
Daniel G. Baker Chief Development Officer 29 Sep 2025
Lucinda Warren Chief Business Officer 29 Sep 2025
Aaron G.L. Fletcher Director 03 Jan 2023
PATRICIA NASSHORN Chief Business Officer 16 Feb 2023

Recent Insider Transactions by Companies or Individuals for Cue Biopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.